Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole

ABSTRACT Background: Chagas disease (CD) treatment is commonly associated with a high incidence of adverse effects. It is crucial to study and update these adverse effects to improve the existing knowledge of which drugs to use and to clarify the information presented to patients. Methods: We ana...

Full description

Bibliographic Details
Main Authors: Cristina Vázquez, Elisa García-Vázquez, Bartolomé Carrilero, Marina Simón, Fuensanta Franco, María Asunción Iborra, Luis Javier Gil-Gallardo, Manuel Segovia
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2023-01-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822023000100305&lng=en&tlng=en
_version_ 1797944938692870144
author Cristina Vázquez
Elisa García-Vázquez
Bartolomé Carrilero
Marina Simón
Fuensanta Franco
María Asunción Iborra
Luis Javier Gil-Gallardo
Manuel Segovia
author_facet Cristina Vázquez
Elisa García-Vázquez
Bartolomé Carrilero
Marina Simón
Fuensanta Franco
María Asunción Iborra
Luis Javier Gil-Gallardo
Manuel Segovia
author_sort Cristina Vázquez
collection DOAJ
description ABSTRACT Background: Chagas disease (CD) treatment is commonly associated with a high incidence of adverse effects. It is crucial to study and update these adverse effects to improve the existing knowledge of which drugs to use and to clarify the information presented to patients. Methods: We analyzed the adverse effects of benznidazole in two cohorts of patients: a large retrospective study and a small prospective study. Results: This large retrospective study described the most and least common adverse effects in our area and characterized our Chagas disease population. This prospective study, along with a close follow-up of the treatment, detected more adverse effects and enhanced the patients’ perception of the disease and treatment. Conclusions: This information is important for preventing non-medical-related withdrawals and for removing baseless fears. Better knowledge of patients could help us provide better care.
first_indexed 2024-04-10T20:46:27Z
format Article
id doaj.art-f1807e617ab4496fa15249f233755058
institution Directory Open Access Journal
issn 1678-9849
language English
last_indexed 2024-04-10T20:46:27Z
publishDate 2023-01-01
publisher Sociedade Brasileira de Medicina Tropical (SBMT)
record_format Article
series Revista da Sociedade Brasileira de Medicina Tropical
spelling doaj.art-f1807e617ab4496fa15249f2337550582023-01-24T07:35:32ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical1678-98492023-01-015610.1590/0037-8682-0384-2022Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with BenznidazoleCristina Vázquezhttps://orcid.org/0000-0002-0762-6108Elisa García-Vázquezhttps://orcid.org/0000-0001-9624-7734Bartolomé Carrilerohttps://orcid.org/0000-0002-0110-603XMarina Simónhttps://orcid.org/0000-0002-6996-5105Fuensanta Francohttps://orcid.org/0000-0001-8306-9326María Asunción Iborrahttps://orcid.org/0000-0002-2550-8500Luis Javier Gil-Gallardohttps://orcid.org/0000-0003-3053-8867Manuel Segoviahttps://orcid.org/0000-0002-3976-103XABSTRACT Background: Chagas disease (CD) treatment is commonly associated with a high incidence of adverse effects. It is crucial to study and update these adverse effects to improve the existing knowledge of which drugs to use and to clarify the information presented to patients. Methods: We analyzed the adverse effects of benznidazole in two cohorts of patients: a large retrospective study and a small prospective study. Results: This large retrospective study described the most and least common adverse effects in our area and characterized our Chagas disease population. This prospective study, along with a close follow-up of the treatment, detected more adverse effects and enhanced the patients’ perception of the disease and treatment. Conclusions: This information is important for preventing non-medical-related withdrawals and for removing baseless fears. Better knowledge of patients could help us provide better care.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822023000100305&lng=en&tlng=enChagasBenznidazoleTrypanosoma cruziToleranceAdherence
spellingShingle Cristina Vázquez
Elisa García-Vázquez
Bartolomé Carrilero
Marina Simón
Fuensanta Franco
María Asunción Iborra
Luis Javier Gil-Gallardo
Manuel Segovia
Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
Revista da Sociedade Brasileira de Medicina Tropical
Chagas
Benznidazole
Trypanosoma cruzi
Tolerance
Adherence
title Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
title_full Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
title_fullStr Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
title_full_unstemmed Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
title_short Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
title_sort tolerance and adherence of patients with chronic chagas disease treated with benznidazole
topic Chagas
Benznidazole
Trypanosoma cruzi
Tolerance
Adherence
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822023000100305&lng=en&tlng=en
work_keys_str_mv AT cristinavazquez toleranceandadherenceofpatientswithchronicchagasdiseasetreatedwithbenznidazole
AT elisagarciavazquez toleranceandadherenceofpatientswithchronicchagasdiseasetreatedwithbenznidazole
AT bartolomecarrilero toleranceandadherenceofpatientswithchronicchagasdiseasetreatedwithbenznidazole
AT marinasimon toleranceandadherenceofpatientswithchronicchagasdiseasetreatedwithbenznidazole
AT fuensantafranco toleranceandadherenceofpatientswithchronicchagasdiseasetreatedwithbenznidazole
AT mariaasuncioniborra toleranceandadherenceofpatientswithchronicchagasdiseasetreatedwithbenznidazole
AT luisjaviergilgallardo toleranceandadherenceofpatientswithchronicchagasdiseasetreatedwithbenznidazole
AT manuelsegovia toleranceandadherenceofpatientswithchronicchagasdiseasetreatedwithbenznidazole